{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/why-literature-reviews-should-be-key-part-your-evidence-generation-strategy#webpage",
"url": "https://www.fortrea.com/insights/why-literature-reviews-should-be-key-part-your-evidence-generation-strategy",
"name": "Why literature reviews should be a key part of your evidence-generation strategy.",
"description": "xplore this Fortrea white paper examining why literature reviews should be a foundational component of evidence-generation strategies across product development, market access, and commercialization. The white paper explores how systematic and targeted literature reviews support the identification of evidence gaps, assessment of published clinical and economic data, and development of robust evidence plans that address the needs of regulators, payers, healthcare providers, and other key stakeholders. It highlights the role of literature reviews in health economics and outcomes research (HEOR), health technology assessment (HTA) submissions, reimbursement planning, comparative value assessment, and value demonstration activities, while providing insight into how evidence synthesis can strengthen decision-making throughout the product lifecycle. The paper also discusses how early and ongoing literature review strategies can help organizations build stronger evidence packages, support market access objectives, optimize resource allocation, and generate the data needed to differentiate products within increasingly competitive healthcare environments."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Why literature reviews should be a key part of your evidence-generation strategy.",
"item": "https://www.fortrea.com/insights/why-literature-reviews-should-be-key-part-your-evidence-generation-strategy"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/why-literature-reviews-should-be-key-part-your-evidence-generation-strategy#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/why-literature-reviews-should-be-key-part-your-evidence-generation-strategy#webpage"
},
"headline": "Literature Reviews and Evidence Generation Strategies for HEOR, HTA, and Evidence Planning | Fortrea White Paper",
"description": "xplore this Fortrea white paper examining why literature reviews should be a foundational component of evidence-generation strategies across product development, market access, and commercialization. The white paper explores how systematic and targeted literature reviews support the identification of evidence gaps, assessment of published clinical and economic data, and development of robust evidence plans that address the needs of regulators, payers, healthcare providers, and other key stakeholders. It highlights the role of literature reviews in health economics and outcomes research (HEOR), health technology assessment (HTA) submissions, reimbursement planning, comparative value assessment, and value demonstration activities, while providing insight into how evidence synthesis can strengthen decision-making throughout the product lifecycle. The paper also discusses how early and ongoing literature review strategies can help organizations build stronger evidence packages, support market access objectives, optimize resource allocation, and generate the data needed to differentiate products within increasingly competitive healthcare environments.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/why-literature-reviews-should-%20be-key-part-of-your-evidence-generation-strategy.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-21",
"dateModified": "2025-02-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/why-literature-reviews-should-%20be-key-part-of-your-evidence-generation-strategy.pdf",
"encodingFormat": "application/pdf"
}
}
]
}